欧盟EMA药品数据库-欧盟集中审批药品（European Medicines Agency Authorisation of Medicines DataBase）

商品名称	适用类别	通用名称	活性成分	产品号	上市许可开发者/申请人/持有人	上市许可日期	许可状态
Gotenfia	Human	golimumab	golimumab	EMEA/H/C/006621	Stada Arzneimittel AG	2026/02/10	Authorised
Aqneursa	Human	L-acetylleucine	L-acetylleucine	EMEA/H/C/006327	Intrabio Ireland Limited	2026/01/19	Authorised
Dawnzera	Human	donidalorsen	donidalorsen	EMEA/H/C/006554	Otsuka Pharmaceutical Netherlands B.V.	2026/01/19	Authorised
Ondibta	Human	insulin glargine	insulin glargine	EMEA/H/C/006136	Gan & Lee Pharmaceuticals Europe GmbH	2026/01/09	Authorised
Waskyra	Human	etuvetidigene autotemcel	genetically modified autologous CD34+ cell enriched population that contains haematopoietic stem and progenitor cells (HSPC) transduced ex vivo using a lentiviral vector encoding the human Wiskott-Aldrich Syndrome (WAS) gene	EMEA/H/C/006525	Fondazione Telethon ETS	2026/01/09	Authorised
VacPertagen	Human	pertussis vaccine (recombinant, acellular, component, adsorbed)	recombinant pertussis toxin;filamentous haemagglutinin	EMEA/H/C/006304	BioNet Europe	2026/01/09	Authorised
Inluriyo	Human	imlunestrant	imlunestrant tosilate	EMEA/H/C/006184	Eli Lilly Nederland B.V.	2026/01/09	Authorised
Austedo	Human	deutetrabenazine	deutetrabenazine	EMEA/H/C/006371	Teva GmbH	2026/01/08	Authorised
GalenVita	Human	germanium (68Ge) chloride;gallium (68Ga) chloride	germanium (68Ge) chloride;gallium (68Ga) chloride	EMEA/H/C/006639	Curium Romania S.R.L.	2026/01/08	Authorised
Teduglutide Viatris	Human	teduglutide	teduglutide	EMEA/H/C/006564	Viatris Limited	2026/01/08	Authorised
Teizeild	Human	teplizumab	teplizumab	EMEA/H/C/005496	Sanofi Winthrop Industrie	2026/01/08	Authorised
Osqay	Human	denosumab	denosumab	EMEA/H/C/006492	Theramex Ireland Limited	2026/01/08	Authorised
Wayrilz	Human	rilzabrutinib	rilzabrutinib	EMEA/H/C/006425	Sanofi B.V.	2025/12/22	Authorised
Imaavy	Human	nipocalimab	nipocalimab	EMEA/H/C/006379	Janssen Cilag International NV	2025/11/28	Authorised
Kyinsu	Human	insulin icodec;semaglutide	insulin icodec;semaglutide	EMEA/H/C/006279	Novo Nordisk A/S	2025/11/24	Authorised
Rivaroxaban Koanaa	Human	rivaroxaban	rivaroxaban	EMEA/H/C/006643	Koanaa Healthcare GmbH	2025/11/21	Authorised
Brinsupri	Human	Brensocatib	Brensocatib monohydrate	EMEA/H/C/005820	Insmed Netherlands B.V.	2025/11/18	Authorised
Xbonzy	Human	denosumab	denosumab	EMEA/H/C/006722	Reddy Holding GmbH	2025/11/17	Authorised
Ponlimsi	Human	denosumab	denosumab	EMEA/H/C/006238	Teva GmbH	2025/11/17	Authorised
Degevma	Human	denosumab	denosumab	EMEA/H/C/006239	Teva GmbH	2025/11/17	Authorised

商品名称Name of medicine	*示例：Zokinvy（英文）
药品通用名或非专利名称International non-proprietary name (INN) / common name	*示例：lonafarnib（英文）
活性成分Active substance	*示例：lonafarnib（英文）
产品号EMA product number	*示例：EMEA/H/C/005271
ATC编号ATC code	*示例：L01EA06
上市许可开发者/申请人/持有人Marketing authorisation developer / applicant / holder	*示例：Janssen
药物治疗学分组Pharmacotherapeutic group	*示例：Antineoplastic
适应症Therapeutic indication	*示例：leukaemia
许可状态Medicine status
上市许可日期Marketing authorisation date	-